Smoking Habit and Mortality: A Meta-analysis
|
|
|
- Lynn Cain
- 10 years ago
- Views:
Transcription
1 Copyright E 2008 Journal of Insurance Medicine J Insur Med 2008;40: MORTALITY Smoking Habit and Mortality: A Meta-analysis Robert M. Shavelle; David R. Paculdo; David J. Strauss; Scott J. Kush Cigarette smoking leads to excess mortality risk. Although it is well known that the risk increases with the number of pack-years of smoking that is, how much a person smokes, or habit there is apparently no published studies that organize and synthesize the evidence on this topic. This paper provides a meta-analysis of the latest published findings relating to cigarette smoking habit and excess mortality. A combined estimate of the relative risk (RR) of death for smokers, stratified by habit (light, medium, or heavy smoking), compared with non-smokers is provided. Address: Life Expectancy Project, th Avenue, San Francisco, CA ; ph: ; [email protected]. Correspondent: Dr. Robert M. Shavelle. Key words: Mortality, smoking, meta-analysis, meta-review, metasynthesis, pack-years, habit, cigarettes/day, severity, all-cause mortality, life expectancy, survival, SMR, standardized mortality ratio, RR, relative risk, HR, hazard ratio, MR, mortality ratio. Received: July 9, 2008 Accepted: November 3, 2008 INTRODUCTION Cigarette smoking leads to excess mortality risk. 1 9 There are literally thousands of studies documenting this finding. Although it is well known that the risk increases with the number of pack-years of smoking that is, how much a person smokes, or habit there do not appear to be any published studies that organize and synthesize the evidence on this topic. Our purpose here is to present a metaanalysis on the latest published findings relating cigarette smoking habit and excess mortality. In addition, we report on original analyses of data from 3 large databases of persons aged 50 and over. Our goal was to compute a combined estimate of the relative risk (RR) of death for smokers, stratified by habit (light, medium, or heavy smoking), compared with non-smokers. We were further interested to see whether and how these RRs varied with age and sex. METHODS Using keywords smoking and mortality, we searched the National Center for Biotechnology Information (NCBI) website of journal articles (PubMed.gov). We then restricted attention (using the Limits feature) to those articles (1) about humans, (2) published in English-only journals, and (3) identified as meta-analyses, yielding
2 SHAVELLE ET AL SMOKING AND MORTALITY studies. Of these, none quantified the allcause mortality risk due to smoking by packyears or habit. It was this paucity of evidence that prompted the present investigation. [Note: Three meta-analyses 6 8 did review cause-specific mortality due to smoking (eg, death to cancer, or injury), but none looked at all-cause mortality.] The starting point for our own metaanalysis was the recent study of Doll et al. 9 Regarding this, PubMed listed 901 studies as related articles. After restricting attention to those articles (1) of humans only research, (2) published in English-only journals since 1990, (3) dealing with cigarette smoking, rather than pipe or cigar, and (4) with results based on the current smoking habits, we identified 13 published articles From these 13 we excluded 2, Ostbye and Taylor (2004) 10 and Murakami et al (2007), 11 because both presented life expectancies rather than increased risks of death such as a relative risk (RR). Additional considerations were that (1) the results of Ostbye and Taylor 10 were based on a model that controlled for a number of covariates, some of which might properly have been thought to be outcome variables due to smoking, and (2) RRs implicit in Murakami et al 11 were provided in an earlier study of the same data. 12 This left 11 studies that addressed the effect of smoking habits on mortality in men, and 9 studies in women. All of these concerned the effect of current habit on subsequent survival; none dealt with the effect of the number of pack-years. Only one of the studies 12 excluded persons with preexisting medical conditions. Some information about the studies we relied upon, and additional calculations we required, are given in Appendix A. As can be seen in Appendix A, each study had its own definition of light, medium, or heavy smoking. Light was defined as less than 10 cigarettes/day in 5 studies, as less than 15 cigarettes per day in 5 studies and as less than 21 in 1 study. Heavy was defined mostly as 20+ or 25+ cigarettes/day. Medium was thus most often in the range of 10 to 25 cigarettes/day. We also carried out original analyses of longitudinal mortality data from (1) the Cardiovascular Health Study (CHS), (2) the Health and Retirement Study (HRS), and (3) the Third National Health and Nutrition Examination Survey (NHANES III) These data and the methods we used are described in Appendix A. For each study (or data set) we recorded the relative risks (relative to never-smokers) for each smoking habit: light, medium, or heavy. Because these same studies often reported on the effect for former smokers, we included this as well. Our goal was to compute a combined estimate of the RR for each smoking habit. Heuristically, one might think of this as a weighted average of the individual estimates given in the various studies, with the weights based on the confidence we place on each estimate. In practice one cannot simply average the RRs. Rather, one must first obtain the underlying parameter estimates, then average these, and then finally convert this back to the overall estimate of RR. Technical details are given in Appendix B. An important consideration was the extent to which each study (a) excluded persons with pre-existing medical conditions, perhaps those due to smoking, and (b) controlled for various co-morbid factors, such as age, sex, race, education, weight, cholesterol, blood pressure, heart disease, and cancer. Studies that excluded persons with medical conditions due to smoking, or controlled for factors related to smoking (eg, blood pressure), would be expected to find lower RRs. Conversely, studies that did not account for sufficient confounding factors (such as age or weight) might find higher RRs. We return to this issue in the results and discussion. RESULTS Table 1 lists the articles and databases included in the final meta-analysis. Most of 171
3 Table 1. Summary of Studies and Results Males # Study Sample Size Average Age Light Medium Heavy Former RR 95% CI Weight RR 95% CI Weight RR 95% CI Weight RR 95% CI Weight 1 Hummer (1.04, 1.63) (1.57, 2.45) (2.1, 3.28) (0.78, 1.23) Prescott (1.7, 2.2) (2.1, 2.7) (2.3, 3.0) (1.06, 1.59) Jacobs (1.17, 1.43) (1.65, 1.93) (1.87, 2.27) (0.78, 1.65) Qiao (0.93, 1.42) (1.48, 2.09) (1.65, 2.37) (0.82, 1.44) Lam (1.23, 1.86) (1.63, 2.47) (2.69, 4.07) Bronnum-Hansen (1.25, 1.53) (1.67, 2.05) (2.08, 3.14) (1.08, 1.31) Doll (1.62, 1.98) (1.96, 2.40) (2.36, 2.88) (1.19, 1.45) Hozawa (1.22, 1.84) (1.44, 2.03) (1.51, 2.14) (1.12, 1.70) Ueshima (0.91, 1.44) (1.03, 1.71) (1.17, 2.04) (0.90, 1.52) Vollset (1.99, 2.53) (2.35, 2.87) (2.71, 3.40) (1.18, 1.46) Ekberg-Aronsson (1.23, 1.67) (1.83, 2.23) (2.10, 2.54) (0.95, 1.17) CHS (0.78, 1.96) (1.65, 2.73) (2.02, 3.99) (1.09, 1.44) HRS (1.25, 1.93) (1.82, 2.74) (1.96, 2.58) (1.12, 1.37) NHANES III (0.98, 2.09) (1.37, 2.43) (1.90, 4.04) (0.97, 1.44) 0.04 Weighted average Females # Study Sample Size Average Age Light Medium Heavy Former RR 95% CI Weight RR 95% CI Weight RR 95% CI Weight RR 95% CI Weight 1 Hummer (1.18, 1.84) (2.08, 3.25) (2.99, 4.68) (1.48, 2.31) Prescott (2.0, 2.5) (2.4, 3.1) (2.9, 4.5) (0.98, 1.47) Al-dalaimy (0.96, 2.14) (1.24, 2.17) (1.32, 3.65) (1.11, 1.55) Lam (1.19, 1.81) (1.49, 2.27) (2.14, 3.24) Bronnum-Hansen (1.23, 1.50) (1.66, 2.03) (2.04, 3.05) (1.07, 1.30) Hozawa (1.04, 2.08) (1.06, 1.94) (0.81, 2.26) (0.56, 2.16) Ueshima (0.99, 1.74) (0.99, 1.74) (0.54, 3.22) (0.76, 1.92) Vollset (1.59, 2.04) (1.82, 2.26) (2.20, 3.12) (1.11, 1.42) Ekberg-Aronsson (1.38, 2.18) (2.07, 2.87) (2.00, 2.92) (1.04, 1.52) CHS (1.23, 2.58) (1.4, 2.19) (2.61, 6.27) (1.03, 1.4) HRS (1.28, 1.99) (1.56, 2.33) (1.95, 2.64) (1.09, 1.31) NHANES III (0.90, 1.96) (1.18, 2.08) (2.10, 4.78) (0.97, 1.37) 0.07 Weighted average
4 SHAVELLE ET AL SMOKING AND MORTALITY the data came from the United States, although there were several each from Asia and Europe. The combined (meta-) estimates of the relative risks for light, medium, and heavy smoking in men were 1.47, 2.02, and 2.38, respectively. The values for women were quite similar, at 1.50, 2.02, and 2.66, respectively. The values for former smokers were 1.21 for men and 1.23 for women. The results did not vary significantly if the last 3 results (CHS, HRS, and NHANES III) were excluded. A plot (not shown) of the RRs against age for the various studies listed in Table 1 did not reveal any trend, in either direction, for either sex. The 6 studies that included 11+ cigarettes/ day in the light group did not yield uniformly higher RRs than the ones with lower limits (1 10). Nor did the studies with a higher threshold for heavy yield uniformly higher RRs than those of the other studies. This suggests that the results are rather robust to the definitional choices. The one study that excluded persons with pre-existing conditions (cardiovascular disease), 12 reported lower RRs than all of the other studies. Most of the studies reported RRs based on (Cox) models that controlled for age, sex, and various co-morbid factors (eg, weight, cholesterol, blood pressure). The few studies that did not control for the comorbid factors that is, control was made only for age and sex reported relatively higher RRs. 9,13,14,17 We found the same to be true in our own analyses of the CHS, HRS, and NHANES databases: The models that included co-morbid factors yielded lower RRs than the ones without these factors. Exclusion of the 5 studies footnoted in the preceding paragraph (ie, references 9, 12 14, and 17) did not appreciably alter the overall findings. For example, the RRs for medium smoking changed from 2.02 to 1.98 in males and from 2.02 to 1.92 in females. In our analysis of the CHS and NHANES databases, we also determined the effect of smoking stratified by pack-years of smoking. Table 2. Relative Risk for Smoking, Stratified by Pack- Years Database Pack-Years Low Medium High CHS NHANES We used the same models as described in Appendix A. The RRs for current smokers with low (0 to 10 pack-years), medium (10 to 30), and high (greater than 30) are shown in Table 2. In separate models that controlled only for age, sex, race, and smoking (not shown), the resulting RRs were only slightly higher (about 10%). For general interest we also report the percentage of males aged 40 to 60 in the NHANES data with the various smoking habits: never (22%), light (15%), medium (14%), heavy (6%), and former (42%). For women the figures were 54%, 12%, 9%, 3%, and 22%, respectively. If the RRs for the male smoking groups (1.00, 1.47, 2.02, 2.38, and 1.21) are weighted by these percentages, the composite is For females we obtain This means, for example, that medium male smokers aged 40 to 60 have 2.02/ times the mortality risk of that in the overall group. Such adjustments may be useful when starting with general population or composite mortality data. DISCUSSION In the present paper we did not perform a meta-analysis of all smoking studies that is, studies that did not account for smoking habit but rather relied upon a simple dichotomy: smoking yes/no. A rule of thumb is that the RR for smokers compared with non-smokers is roughly 2, and this comports with the RR for medium smoking noted above: Indeed, the RRs for smokers vs nonsmokers implicit in the VBT 2001 is approximately 2 for persons aged at time of 173
5 underwriting (and for the first few years of the select period). 26 For example, males who smoke have a RR of 2.35 at starting age 60, 2.18 at starting age 70, and 1.85 at starting age 80. The corresponding values for females are 2.35, 1.88, and It is notable that, in the study and data reviewed here, the RRs did not appear to vary significantly by the average study population age or sex. In many conditions we find that females have a higher RR. If a condition confers a constant excess death rate (EDR) to both sexes, then females, who have a lower baseline mortality rate than males, will have a larger corresponding RR (though a lower total mortality risk). But, as can be seen in Table 1, this was not the case here (the rather modest difference in RRs for heavy smoking being the lone exception). Further, in most chronic conditions, the RR decreases with age, 27,28 sometimes quite dramatically, and thus age is usually a key factor to be accounted for in any metaanalysis. Indeed, the RRs implicit in the VBT 2001 do show a decline with age. First, we see a slight downward trend in the VBT RRs noted above (2.35 to 2.18 to 1.85 in males, and 2.35 to 1.88 to 1.46 in females). Second, with increasing policy duration the imputed RR declines. For example, for males aged 60, the current RR is 2.35, decreasing to 1.97 by duration 10 years and 1.43 by duration 20 years. In nearly every other chronic condition (eg, heart disease, obesity, diabetes) the RR decreases both with initial age and duration. It remains to be determined why we did not observe a similar trend in the RRs reported here. A related issue concerns the age at which study participants began smoking. Certainly a 60-year-old, pack-per-day, male smoker who began at age 15, say, has a higher risk of death than a pack-per-day smoker who began only at age 50. It is unclear whether among persons with identical pack-years of smoking, the one who started earlier has a higher risk. An implicit assumption in the analyses presented here is that the various populations studied were similar in their respective mixtures of ages of starting smoking. There does not appear to be detailed information on this topic. It is known, however, that most persons begin smoking as young adults. To this extent, therefore, the issue is likely not a major one in explaining the differences between the reported RRs. The RRs shown here for former smokers may be thought of as averages over (1) those who quit many years in the past, (2) those who quit more recently, and who have an RR close to that of current smokers, and (3) those who quit neither long ago nor recently. It is known that smokers who quit in their youth (eg, 30 s) have long-term survival prospects very similar to that of never smokers. 9 In contrast, persons with significant pack-years of smoking, despite quitting many years ago, nevertheless do still experience significant sequelae, such as atheroslcerosis, stroke, or cancer. Some studies 16,22 reported RRs for former smokers according to (1) pack-years, (2) daily habit when they were smoking, or (3) how recently they had quit smoking. A proper meta-analysis of former smokers should stratify on at least one of these characteristics, much as we have done here for current smokers. For some applications it might be helpful to have ratings that exclude persons with preexisting conditions due to smoking; for others it may not. Similarly, for some applications it may be helpful to have ratings that control for many co-morbid factors, while for others it may not. The studies reviewed here were not uniform in their population acceptance criteria or in the number and type of risk factors that were controlled for in the analyses. The reader may thus prefer the relative risks of some selected studies over those presented in others. It is common to rate smoking using a simple yes/no dichotomy. Yet as we have documented, heavy smokers have substantially higher mortality risks than average 174
6 SHAVELLE ET AL SMOKING AND MORTALITY smokers, and light smokers have substantially lower risks. To the extent that reliable information on a proposed insured s smoking habits is available, it can now be used in underwriting. Editorial note: The Editor of the Journal of Insurance Medicine served as a part-time paid medical consultant to the first author and disqualified himself from evaluating this manuscript. Evaluation was performed by 2 independent external peer reviewers. APPENDIX A: NOTES ON USE OF THE STUDIES, LISTED BY FIRST AUTHOR AND CALENDAR YEAR. Hummer 1998: 13 The total number of persons was 21,936. Approximately 3,000 were in our target age range (which is why we reported age 60 in the Table). The following mortality rates were given for women (Table 1) and men (Table 2): never smokers, long term former, recent quitter, current light (,10 cigarettes/day), current heavy (25+ cigarettes/day), and overall. We assumed that the medium smoking rates were mid-way between those for light and heavy. We computed relative risks (RR) for smokers compared with never smokers. Confidence intervals (CI) and standard errors of the rates were not given in the study. It can be shown that the standard error of the parameter is approximately We used this to construct the CI in the table. Prescott 1998: 14 Sample sizes are from Table 1, as are the average ages. RRs and CIs were given in Tables 3 and 4. Light smoking was defined as 15 or less g/day, medium g/day, and heavy g/day (1 g 5 1 cigarette; 3 g 5 1 cheroot; 5 g 5 1 cigar). CIs for former smokers were derived under the assumption that the sample size was J that of smokers, so the CI was twice as wide, giving a standard error of approximately 2 * Separate RRs for former smokers based on habit were shown in Table 3, but were not used here. Jacobs 1999: 15 RRs and CIs are given in Table 3. Light smoking was defined as 1 9 cigarettes/day, and medium as 10+. The RR for heavy smoking was not given in the study. But the study estimated the RR per pack as 1.7. For the present purposes we assumed that heavy smoking was, on average, 2 packs/day. For simplicity, we also assumed that the RR for heavy smoking was (1.7) and that the CI was the square of the CI for medium smoking (it can be shown that this leads to a slight overestimation of the RR for heavy smoking, but that the confidence interval is of the correct width). Qiao 2000: 16 Light smoking was 1 9/day, avearge 10 19, and heavy 20+. RRs and CIs are given in Table 3. We used the 35-year follow-up period, and for ex-smokers we reported those with medium habits (10 19/day). Al-dalaimy 2001: 22 All participants were female and had type 2 diabetes. The total sample size was from Table 1 (1986 questionnaire only). Ages were computed using Table 2. Smoking habit was defined as light , medium , heavy For the reader concerned about the inclusion of this unusual study, we note that (a) exclusion did not materially affect the results, and (b) the RRs from this study were rather similar to those of the other studies. Lam 2001: 17 Smoking habits were defined as light , medium , and heavy Sample sizes were for males age (cases plus control) from Table 1. RRs were from Table 5. CIs were not given. We estimated these as follows. For the combined group of males smokers with results shown in Table 3, the standard error of the parameter estimate can be shown to be about For the stratified groups, therefore, the sample sizes were about 1/3. Thus, the standard errors are about sqrt(3)* for males and 0.13 for females. Bronnum-Hansen 2004: 18 Sample sizes were not given by sex. The total figure was thus divided in two. We based calculations 175
7 on theirs for age 30, so 30 is shown at the age in our Table. Smoking habit was defined in the study as moderate 1 14 g/day (which we placed in our light group), and heavy 15+g/day (which we took to be medium ). RRs were not given in the study; instead, life expectancies were shown in Table 1. By trial and error we found the RR that yielded the desired difference in life expectancy by smoking habit. CIs were not given. For our heavy group we used the produce of the RRs for the light and medium groups. Because the sample sizes were similar to those in the Prescott study (above), we assumed that the standard error of the parameter estimate was similar as well. Doll 2004: 9 Sample size was those born since The average age was at the average start of follow-up. Smoking habit was defined as light , medium , heavy RRs were given in Table 3. CIs were not given. Again, because the sample sizes were similar to those in the Prescott study (above), we assumed that the standard error of the parameter estimate was similar as well. Hozawa 2004: 19 Sample sizes were in Table 1. Ages were computed from the values in Table 1. Smoking habit was defined as medium , heavy RRs and CIs were given in Table 2. Ueshima 2004: 12 Sample sizes were in Table 1. Ages were computed from the values in Table 1. Smoking habit was defined as light , heavy Values for medium were assumed to be the average of these. RRs and CIs were given in Table 3. Vollset 2006: 20 Smoking habit defined as light 5 1 9, medium , heavy RRs and CIs in Table 2. Ekberg-Aronsson 2007: 21 Sample sizes in Table 2. Age computed from the values in Table 2. Smoking habit defined as light 5 1 9, medium , heavy grams/day (1 g 5 1 cigarette, 3 g 5 1 cheroot, 5 g 5 1 cigar). RRs and CIs in Table 4. CHS: 23 Begun in 1988, the Cardiovascular Health Study (CHS) is a study of risk factors for development and progression of coronary heart disease and stroke in people aged 65 years and older. A total of 5,888 participants were recruited for this study. In addition to smoking history and status, the final multivariate Cox model adjusted for race, gender, age, weight, and various major medical conditions. The relative risk (RR) for smoking did not appear to vary significantly by age, gender, or other demographic variables. Smoking habit was defined as light 5 1 9, medium , heavy HRS: 24 Originally started in 1992, the University of Michigan Health and Retirement Study (HRS) is an ongoing survey of more than 22,000 Americans over the age of 50 every 2 years. In addition to smoking history and status, the final multivariate Cox model adjusted for race, gender, age, weight, and various major medical conditions. As above, the relative risk (RR) for smoking did not appear to vary significantly by age, gender, or other demographic variables. Smoking habit was defined as light 5 1 9, medium , heavy NHANES III: 25 The Third National Health and Nutrition Examination Survey (NHANES III) was conducted between 1988 to 1994 by the National Center for Health Statistics on a nationwide probability sample of approximately 33,994 persons aged 2 months and older. We restricted the data to persons age 50 and older who had a reliable smoking history and pulmonary test. In addition to smoking history and status, the final multivariate Cox model adjusted for race, gender, education, age, weight, and various major medical conditions. Again, the relative risk (RR) for smoking did not appear to vary significantly by age, gender, or other demographic variables. Smoking habit was defined as light 5 1 9, medium , heavy APPENDIX B: TECHNICAL DETAILS ON THE METHODS 1. For each study we were given (or computed) the relative risk (RR). Denote this as RR i,i5 1, 2, 176
8 SHAVELLE ET AL SMOKING AND MORTALITY 2. Define the underlying parameter as b i 5 ln(rri), or RR i 5 exp[b i ], where ln is the natural logarithm. Note: The values of b are given in statistical output, for example, from a Cox proportional hazard regression model, as are the confidence intervales (CI s) forb. 3. We recorded the 95% CI for each relative risk. If a CI was not available, we estimated one using reasonable assumptions, as indicated in the Appendix. 4. It can also be shown that if a 95% CI for the RR is given by (x,y), then the 95% confidence interval for b i is [ln(x) 2 2s i, ln(y) + 2s I ], where s i is the standard error of the parameter estimate. 5. Thus, given the interval (x,y) we can determine the comparable interval for b i, and also find s 2 i. 6. The weight to be given to the parameter from the i th study was w i 5 (1/s 2 i )/S(1/ s 2 i ), where S(1/s 2 i ) is the sum of all the inverse variances, and the weights clearly sum to 1. That is, the weight is proportional to the inverse of the variances, as is standard. Hence, a small variance means that the particular parameter is given comparably more weight in the calculations, and conversely. Equivalently, a comparable narrow confidence interval is associated with more weight. 7. We then computed the meta-estimate (B) of the parameter by taking a weighted average of the individual parameter estimates, B 5 Sw i b i. Finally, we computed the meta-estimate of the relative risk (RR) by taking the exponent of the metaestimate of the parameter, RR 5 exp[b]. REFERENCES 1. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults United States, MMWR Morb Mortal Wkly Rep. 2008;57: Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults United States, MMWR Morb Mortal Wkly Rep. 2006;55: Jha P, Jacob B, Gajalakshmi V, et al. A nationally representative case-control study of smoking and death in India. N Engl J Med. 2008;358: Taylor DH Jr, Hasselblad V, Henley J, et al. Benefits of smoking cessation for longevity. Am J Public Health. 2002;92: Richards H, Abele JR. Life and worklife expectancies. Tucson: Lawyers & Judges; Mucha L, Stephenson J, Morandi N, Dirani R. Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gender Med. 2006;3: Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, Boyle P. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122: Leistikow BN, Martin DC, Jacobs J, Rocke DM. Smoking as a risk factor for injury death: a metaanalysis of cohort studies. Prev Med. 1998;27: Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years observations on male British doctors. BMJ. doi: /bmj AE (published 22 June 2004). 10. Ostbye T, Taylor DH Jr. The effect of smoking on years of healthy life (YHL) lost among middleaged and older Americans. HRS: Health Services Research. 2004;39: Murakami Y, Ueshima H, Okamura T, et al. Life expectancy among Japanese of different smoking status in Japan: NIPPON DATA80. J Epidemiol. 2007;17: Ueshima H, Choudhury SR, Okayama A, et al. Cigarette smoking as a risk factor for stroke death in Japan. Stroke. 2004;35: Hummer RA, Nam CB, Rogers RG. Adult mortality differentials associated with cigarette smoking in the USA. Population Research and Policy Review. 1998;17: Prescott E, Osler M, Andersen PK, et al. Mortality in women and men in relation to smoking. Int J Epidemiol. 1998;27: Jacobs DR Jr, Adachi H, Mulder I, et al. Cigarette smoking and mortality risk. Arch Intern Med. 1999;159: Qiao Q, Tervahauta M, Nissinen A, Tuomilehto J. Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middleaged Finnish men. Euro Heart J. 2000;21: Lam TH, Ho SY, Hedley AJ, Mak KH, Peto R. Mortality and smoking in Hong Kong: casecontrol study of all adult deaths in BMJ. 2001;323:
9 18. Bronnum-Hansen H, Juel K. Impact of smoking on the social gradient in health expectancy in Denmark. J Epidemiol and Community Health. 2004;58: Hozawa A, Ohkubo T, Yamaguchi J, et al. Cigarette smoking and mortality in Japan: the Miyagi Cohort Study. J Epidemiol. 2004;47:S12 S Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med. 2006;144: Ekberg-Aronsson M, Nilsson PM, Nilsson JA, Lofdahl CG, Lofdahl K. Mortality risks among heavy-smokers with special reference to women: a long-term follow-up of an urban population. Euro J Epidemiol. 2007;22: Al-Delaimy WK, Willett WC, Manson JE, et al. Smoking and mortality among women with Type 2 Diabetes. Diabetes Care. 2001;24: National Heart, Lung, and Blood Institute (NHLBI). National Institute of Neurological Disorders and Stroke (NINDS). Cardiovascular Health Study (CHS), Year 12 Public Use Data. Produced and distributed by the University of Washington with funding from the National Heart, Lung, and Blood Institute (contract numbers N01-HC through N01-HC-85086, N01- HC-35129, N01 HC-15103, N01 HC-55222, N01- HC-75150, N01-HC-45133, grant number U01 HL080295). Seattle, WA, The CHS is conducted and supported by the NHLBI in collaboration with the CHS Study Investigators. This manuscript was prepared using a limited access dataset obtained by the NHLBI and does not necessarily reflect the opinions of the CHS Study or the NHLBI. 24. Health and Retirement Study, HRS 2002 Core (Final V2.0) public use dataset. Produced and distributed by the University of Michigan with funding from the National Institute on Aging (grant number NIA U01AG009740). Ann Arbor, MI, Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Available at: nh3data.htm. 26. Society of Actuaries Mortality Task Force Valuation basic mortality table (VBT). Schaumburg, Illinois: Society of Actuaries; Strauss DJ, Vachon PJ, Shavelle RM. Estimation of future mortality rates and life expectancy in chronic medical conditions. J Insur Med. 2005;37: Anderson TW. Life expectancy in court: A textbook for doctors and lawyers. Vancouver BC: Teviot Press;
The American Cancer Society Cancer Prevention Study I: 12-Year Followup
Chapter 3 The American Cancer Society Cancer Prevention Study I: 12-Year Followup of 1 Million Men and Women David M. Burns, Thomas G. Shanks, Won Choi, Michael J. Thun, Clark W. Heath, Jr., and Lawrence
Mortality Assessment Technology: A New Tool for Life Insurance Underwriting
Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Guizhou Hu, MD, PhD BioSignia, Inc, Durham, North Carolina Abstract The ability to more accurately predict chronic disease morbidity
Mortality Experience in the Elderly in the Impairment Study Capture System
JOURNAL OF INSURANCE MEDICINE Copyright E 2008 Journal of Insurance Medicine J Insur Med 2008;40:110 115 MORTALITY Mortality Experience in the Elderly in the Impairment Study Capture System Thomas Ashley,
Randomized trials versus observational studies
Randomized trials versus observational studies The case of postmenopausal hormone therapy and heart disease Miguel Hernán Harvard School of Public Health www.hsph.harvard.edu/causal Joint work with James
Advanced Statistical Analysis of Mortality. Rhodes, Thomas E. and Freitas, Stephen A. MIB, Inc. 160 University Avenue. Westwood, MA 02090
Advanced Statistical Analysis of Mortality Rhodes, Thomas E. and Freitas, Stephen A. MIB, Inc 160 University Avenue Westwood, MA 02090 001-(781)-751-6356 fax 001-(781)-329-3379 [email protected] Abstract
Appendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
Exercise Answers. Exercise 3.1 1. B 2. C 3. A 4. B 5. A
Exercise Answers Exercise 3.1 1. B 2. C 3. A 4. B 5. A Exercise 3.2 1. A; denominator is size of population at start of study, numerator is number of deaths among that population. 2. B; denominator is
Albumin and All-Cause Mortality Risk in Insurance Applicants
Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH
RR833. The joint effect of asbestos exposure and smoking on the risk of lung cancer mortality for asbestos workers (1971-2005)
Health and Safety Executive The joint effect of asbestos exposure and smoking on the risk of lung cancer mortality for asbestos workers (1971-2005) Prepared by the Health and Safety Laboratory for the
New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine
New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine Disclosures & Relevant Relationships I have nothing to disclose No financial conflicts Editor,
Preliminary Report on. Hong Kong Assured Lives Mortality and Critical Illness. Experience Study 2000-2003
Preliminary Report on Hong Kong Assured Lives Mortality and Critical Illness Experience Study 2000-2003 Actuarial Society of Hong Kong Experience Committee ASHK - Hong Kong Assured Lives Mortality and
S moking is considered to be an important cause of
i62 RESEARCH PAPER Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan M C Yang, C Y Fann, C P Wen, T Y Cheng... Tobacco Control 2005;14(Suppl
Social inequalities in all cause and cause specific mortality in a country of the African region
Social inequalities in all cause and cause specific mortality in a country of the African region Silvia STRINGHINI 1, Valentin Rousson 1, Bharathi Viswanathan 2, Jude Gedeon 2, Fred Paccaud 1, Pascal Bovet
Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD
1 Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD Executive Summary: The presence of low urine creatinine at insurance testing is associated with increased
Pricing the Critical Illness Risk: The Continuous Challenge.
Pricing the Critical Illness Risk: The Continuous Challenge. To be presented at the 6 th Global Conference of Actuaries, New Delhi 18 19 February 2004 Andres Webersinke, ACTUARY (DAV), FASSA, FASI 9 RAFFLES
A Comparison of Period and Cohort Life Tables Accepted for Publication in Journal of Legal Economics, 2011, Vol. 17(2), pp. 99-112.
A Comparison of Period and Cohort Life Tables Accepted for Publication in Journal of Legal Economics, 2011, Vol. 17(2), pp. 99-112. David G. Tucek Value Economics, LLC 13024 Vinson Court St. Louis, MO
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
Beyond Age and Sex: Enhancing Annuity Pricing
Beyond Age and Sex: Enhancing Annuity Pricing Joelle HY. Fong The Wharton School (IRM Dept), and CEPAR CEPAR Demography & Longevity Workshop University of New South Wales 26 July 2011 Motivation Current
ECONOMIC COSTS OF PHYSICAL INACTIVITY
ECONOMIC COSTS OF PHYSICAL INACTIVITY This fact sheet highlights the prevalence and health-consequences of physical inactivity and summarises some of the key facts and figures on the economic costs of
African Americans & Cardiovascular Diseases
Statistical Fact Sheet 2013 Update African Americans & Cardiovascular Diseases Cardiovascular Disease (CVD) (ICD/10 codes I00-I99, Q20-Q28) (ICD/9 codes 390-459, 745-747) Among non-hispanic blacks age
Gender and Smoker Distinct Mortality Table Development
Gender and moker Distinct Mortality Table Development yamal K. Ghosh, FA, MAAA Dr. riram Krishnaswamy, FAI [email protected] Written for and presented at 7 th GCA, ew Delhi 15-16, February, 2005 ubject
Hormones and cardiovascular disease, what the Danish Nurse Cohort learned us
Hormones and cardiovascular disease, what the Danish Nurse Cohort learned us Ellen Løkkegaard, Clinical Associate Professor, Ph.d. Dept. Obstetrics and Gynecology. Hillerød Hospital, University of Copenhagen
EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA
EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP
Underwriting Critical Illness Insurance: A model for coronary heart disease and stroke
Underwriting Critical Illness Insurance: A model for coronary heart disease and stroke Presented to the 6th International Congress on Insurance: Mathematics and Economics. July 2002. Lisbon, Portugal.
Facts about Diabetes in Massachusetts
Facts about Diabetes in Massachusetts Diabetes is a disease in which the body does not produce or properly use insulin (a hormone used to convert sugar, starches, and other food into the energy needed
Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
Non-response bias in a lifestyle survey
Journal of Public Health Medicine Vol. 19, No. 2, pp. 203-207 Printed in Great Britain Non-response bias in a lifestyle survey Anthony Hill, Julian Roberts, Paul Ewings and David Gunnell Summary Background
PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Elizabeth Comino Centre fo Primary Health Care and Equity 12-Aug-2015
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
Coronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
Longevity Risk in the United Kingdom
Institut für Finanz- und Aktuarwissenschaften, Universität Ulm Longevity Risk in the United Kingdom Stephen Richards 20 th July 2005 Copyright c Stephen Richards. All rights reserved. Electronic versions
Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health
Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health Introduction Reader (Statistics and Epidemiology) Research team epidemiologists/statisticians/phd students Primary care
Enhanced Annuities in Asia
Enhanced Annuities in Asia A Case Study Cord-Roland Rinke, Life & Health Longevity Beijing, 6th - 7th September 2013 Disclaimer The information provided in this presentation does in no way whatsoever constitute
Does smoking impact your mortality?
An estimated 25% of the medically underwritten, assured population can be classified as smokers Does smoking impact your mortality? Introduction Your smoking habits influence the premium that you pay for
Trends in Life Expectancy and Causes of Death Following Spinal Cord Injury. Michael J. DeVivo, Dr.P.H.
Trends in Life Expectancy and Causes of Death Following Spinal Cord Injury Michael J. DeVivo, Dr.P.H. Disclosure of PI-RRTC Grant James S. Krause, PhD, Holly Wise, PhD; PT, and Emily Johnson, MHA have
Part 4 Burden of disease: DALYs
Part Burden of disease:. Broad cause composition 0 5. The age distribution of burden of disease 6. Leading causes of burden of disease 7. The disease and injury burden for women 6 8. The growing burden
Diabetes Prevention in Latinos
Diabetes Prevention in Latinos Matthew O Brien, MD, MSc Assistant Professor of Medicine and Public Health Northwestern Feinberg School of Medicine Institute for Public Health and Medicine October 17, 2013
FACILITATOR/MENTOR GUIDE
FACILITATOR/MENTOR GUIDE Descriptive analysis variables table shells hypotheses Measures of association methods design justify analytic assess calculate analysis problem stratify confounding statistical
Life Settlement Characteristics and Mortality Experience for Two Providers
Prepared by: Milliman, Inc. David Cook FSA, MAAA Glenn Ezell MS, MBA Life Settlement Characteristics and Mortality Experience for Two Providers , whose corporate offices are in Seattle, serves the full
Critical Illness insurance AC04 diagnosis rates
Health and care conference 2011 Dave Heeney and Dave Grimshaw, CMI Critical Illness Committee Critical Illness insurance AC04 diagnosis rates 20 May 2011 2010 The Actuarial Profession www.actuaries.org.uk
An Application of the G-formula to Asbestos and Lung Cancer. Stephen R. Cole. Epidemiology, UNC Chapel Hill. Slides: www.unc.
An Application of the G-formula to Asbestos and Lung Cancer Stephen R. Cole Epidemiology, UNC Chapel Hill Slides: www.unc.edu/~colesr/ 1 Acknowledgements Collaboration with David B. Richardson, Haitao
Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
PREFERRED UNDERWRITING CLASSIFICATIONS
PREFERRED UNDERWRITING CLASSIFICATIONS term ADVISOR GUIDE ABOUT EQUITABLE LIFE OF CANADA Equitable Life is one of Canada s largest mutual life insurance companies. For generations we ve provided policyholders
2009 Mississippi Youth Tobacco Survey. Office of Health Data and Research Office of Tobacco Control Mississippi State Department of Health
9 Mississippi Youth Tobacco Survey Office of Health Data and Research Office of Tobacco Control Mississippi State Department of Health Acknowledgements... 1 Glossary... 2 Introduction... 3 Sample Design
The association between health risk status and health care costs among the membership of an Australian health plan
HEALTH PROMOTION INTERNATIONAL Vol. 18, No. 1 Oxford University Press 2003. All rights reserved Printed in Great Britain The association between health risk status and health care costs among the membership
Testing for Adverse Selection Using Micro Data on Automatic Renewal Term Life Insurance
Testing for Adverse Selection Using Micro Data on Automatic Renewal Term Life Insurance Shinichi Yamamoto Department of Economics, Ritsumeikan University Kyoto, Japan [email protected] Takau Yoneyama
NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)
NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia Produced by: National Cardiovascular Intelligence Network (NCVIN) Date: August 2015 About Public Health England Public Health England
Accurium SMSF Retirement Insights
Accurium SMSF Retirement Insights SMSF Trustees healthier, wealthier and living longer Volume 2 April 2015 Our research indicates that SMSF trustees are healthier, wealthier and will live longer than the
Quantifying Life expectancy in people with Type 2 diabetes
School of Public Health University of Sydney Quantifying Life expectancy in people with Type 2 diabetes Alison Hayes School of Public Health University of Sydney The evidence Life expectancy reduced by
Epidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613
Epidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613 1 Definition Hypertension is a chronic medical condition in which the blood pressure in the arteries is elevated. 2 Primary
Listen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
Global Demographic Trends and their Implications for Employment
Global Demographic Trends and their Implications for Employment BACKGROUND RESEARCH PAPER David Lam and Murray Leibbrandt Submitted to the High Level Panel on the Post-2015 Development Agenda This paper
Missing data and net survival analysis Bernard Rachet
Workshop on Flexible Models for Longitudinal and Survival Data with Applications in Biostatistics Warwick, 27-29 July 2015 Missing data and net survival analysis Bernard Rachet General context Population-based,
Tobacco Use in Canada: Patterns and Trends. 2012 Edition
Tobacco Use in Canada: Patterns and Trends 212 Edition Tobacco Use in Canada: Patterns and Trends 212 Edition This report was prepared by Jessica Reid, MSc, and David Hammond, PhD. Data analysis was completed
Street Smart: Demographics and Trends in Motor Vehicle Accident Mortality In British Columbia, 1988 to 2000
Street Smart: Demographics and Trends in Motor Vehicle Accident Mortality In British Columbia, 1988 to 2000 by David Baxter 3-Year Moving Average Age Specific Motor Vehicle Accident Death Rates British
The Adverse Health Effects of Cannabis
The Adverse Health Effects of Cannabis Wayne Hall National Addiction Centre Kings College London and Centre for Youth Substance Abuse Research University of Queensland Assessing the Effects of Cannabis
SAMA Working Paper: POPULATION AGING IN SAUDI ARABIA. February 2015. Hussain I. Abusaaq. Economic Research Department. Saudi Arabian Monetary Agency
WP/15/2 SAMA Working Paper: POPULATION AGING IN SAUDI ARABIA February 2015 By Hussain I. Abusaaq Economic Research Department Saudi Arabian Monetary Agency Saudi Arabian Monetary Agency The views expressed
CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal
CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal 1. STUDY TITLE: Longitudinal Assessment of Chronic Health Conditions: The Aging of Childhood Cancer Survivors 2. WORKING GROUP AND INVESTIGATORS:
Racial and Ethnic Disparities in Maternal Mortality in the United States
Racial and Ethnic Disparities in Maternal Mortality in the United States KYRIAKOS S. MARKIDES, PHD UNIVERSITY OF TEXAS MEDICAL BRANCH GALVESTON, TEXAS PRESENTED AT THE HOWARD TAYLOR INTERNATIONAL SYMPOSIUM
A Simple Method for Estimating Relative Risk using Logistic Regression. Fredi Alexander Diaz-Quijano
1 A Simple Method for Estimating Relative Risk using Logistic Regression. Fredi Alexander Diaz-Quijano Grupo Latinoamericano de Investigaciones Epidemiológicas, Organización Latinoamericana para el Fomento
The Development of Impaired Annuity Markets in the UK and elsewhere
The Development of Impaired Annuity Markets in the UK and elsewhere Insuring the Health of an Ageing Population November 2013, Zurich Peter Banthorpe, Head of UK Research and Development November 18, 2013
Smoking in the United States Workforce
P F I Z E R F A C T S Smoking in the United States Workforce Findings from the National Health and Nutrition Examination Survey (NHANES) 1999-2002, the National Health Interview Survey (NHIS) 2006, and
U.S. Individual Life Insurance Persistency
A Joint Study Sponsored by LIMRA and the Society of Actuaries Full Report Cathy Ho Product Research 860.285.7794 [email protected] Nancy Muise Product Research 860.285.7892 [email protected] A 2009 Report
Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
PREFERRED UNDERWRITING
PREFERRED UNDERWRITING For Solution 10 & Solution 20 Criteria Guide 2015 FOR ADVISOR USE ONLY Contents About this guide...1 Preferred underwriting...1 Availability...1 Risk classifications...1 Standard
Main Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
Review. Life expectancy in cerebral palsy: an update
Life expectancy in cerebral palsy: an update Review David Strauss* PhD FASA; Jordan Brooks BS, Life Expectancy Project, San Francisco, CA, USA; Lewis Rosenbloom FRCPCH, Royal Liverpool Children s NHS Trust,
Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care
Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care Michelle A. Albert MD MPH Treacy S. Silbaugh B.S, John Z. Ayanian MD MPP, Ann Lovett RN
Statistical Bulletin. National Life Tables, United Kingdom, 2011-2013. Key Points. Summary. Introduction
Statistical Bulletin National Life Tables, United Kingdom, 2011-2013 Coverage: UK Date: 25 September 2014 Geographical Area: Country Theme: Population Key Points A newborn baby boy could expect to live
Design Population-based retrospective cohort study.
Mortality Following Inpatient Addictions Treatment Role of Tobacco Use in a Community Based Cohort Richard D. Hurt, MD; Kenneth P. Offord, MS; Ivana T. Croghan, PhD; Leigh Gomez-Dahl; Thomas E. Kottke,
Texas Diabetes Fact Sheet
I. Adult Prediabetes Prevalence, 2009 According to the 2009 Behavioral Risk Factor Surveillance System (BRFSS) survey, 984,142 persons aged eighteen years and older in Texas (5.4% of this age group) have
Advanced Quantitative Methods for Health Care Professionals PUBH 742 Spring 2015
1 Advanced Quantitative Methods for Health Care Professionals PUBH 742 Spring 2015 Instructor: Joanne M. Garrett, PhD e-mail: [email protected] Class Notes: Copies of the class lecture slides
Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial
Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Connie N. Hess, MD, MHS, Stefan James, MD, PhD, Renato D. Lopes, MD, PhD, Daniel M. Wojdyla,
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources
Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources James Floyd, MD, MS Sep 17, 2015 UW Hospital Medicine Faculty Development Program Objectives Become more
T he relation between smoking and injury was not
i28 RESEARCH PAPER Excess injury mortality among smokers: a neglected tobacco hazard C P Wen, S P Tsai, T Y Cheng, H T Chan, W S I Chung, C J Chen... Tobacco Control 2005;14(Suppl I):i28 i32. doi: 10.1136/tc.2003.005629
3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%
S What is Heart Failure? 1,2,3 Heart failure, sometimes called congestive heart failure, develops over many years and results when the heart muscle struggles to supply the required oxygen-rich blood to
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING
Personal Training Health Screening Questionnaire
Personal Training Health Screening Questionnaire Personal Information Today s date: Title: Dr. Mr. Mrs. Ms. Name: / Birth date: Last name First name Age: Address: Phone: (home) City: Phone: (work) Province:
Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008
Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,
Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden
596500SJP0010.1177/1403494815596500B. Järvholm and A. BurdorfAsbestos ban reduces mesothelioma incidence research-article2015 Scandinavian Journal of Public Health, 1 7 Original Article Emerging evidence
Health risk assessment: a standardized framework
Health risk assessment: a standardized framework February 1, 2011 Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention Leading causes of death in the U.S. The 5 leading causes
Canadian Individual Critical Illness Insurance Morbidity Experience
Morbidity Study Canadian Individual Critical Illness Insurance Morbidity Experience Between Policy Anniversaries in 2002 and 2007 Using Expected CIA Incidence Tables from July 2012 Individual Living Benefits
Butler Memorial Hospital Community Health Needs Assessment 2013
Butler Memorial Hospital Community Health Needs Assessment 2013 Butler County best represents the community that Butler Memorial Hospital serves. Butler Memorial Hospital (BMH) has conducted community
Multiple logistic regression analysis of cigarette use among high school students
Multiple logistic regression analysis of cigarette use among high school students ABSTRACT Joseph Adwere-Boamah Alliant International University A binary logistic regression analysis was performed to predict
